DPI 386 Nasal Gel for the Prevention of Nausea Associated With Motion Sickness

Condition:   Motion Sickness Interventions:   Drug: DPI-386 Nasal Gel;   Drug: DPI-386 Placebo Nasal Gel;   Drug: Transderm Scop® Sponsor:   Repurposed Therapeutics, Inc. Terminated
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials